Praxis Power2 study for Focal Epilepsy About the study? A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures. Purpose of the study? The main purpose of this research is to see how well vormatrigine works for treating focal onset seizures compared with placebo, as well as its […]
Praxis Power2 study Read More »
BMS TARGET-TAU This study is being done to learn more about the safety and efficacy of an investigational medication called BMS-986446 in adults aged 50-80 years with mild cognitive impairment due to Alzheimer’s disease, or mild Alzheimer’s dementia. Inclusion Criteria: Are 50-80 years old Have a diagnosis of mild cognitive impairment due to Alzheimer’s disease,
PIPELINE/CONTINEUM VISTA This is a randomized, double-blind study of PIPE-307 or placebo to see if it can help patients with relapsing-remitting multiple sclerosis. Inclusion Criteria: 18-50 years of age, a diagnosis of relapsing-remitting multiple sclerosis Stable immunomodulatory treatment Diagnosed within the last 10 years Without clinical MS relapse or treatment with corticosteroids within last 6
PIPELINE/CONTINEUM VISTA Read More »
